olmesartan has been researched along with anastrozole in 1 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (anastrozole) | Trials (anastrozole) | Recent Studies (post-2010) (anastrozole) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 1,568 | 354 | 686 |
| Protein | Taxonomy | olmesartan (IC50) | anastrozole (IC50) |
|---|---|---|---|
| Aromatase | Homo sapiens (human) | 0.1443 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.0036 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.0015 | |
| UDP-glucuronosyltransferase 1A4 | Homo sapiens (human) | 4.72 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
1 other study(ies) available for olmesartan and anastrozole
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |